Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
69
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical characteristics of testicular seminoma in individuals in West China: a 10-year follow-up study

Zeyu Chen1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China;2 West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China
,
Shi Qiu1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China;3 Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
,
Dehong Cao1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China
,
Jianbing Guo1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China;2 West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China
,
Bo Chen1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China;2 West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China
,
Yin Huang1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China;2 West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China
,
Li Lai1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China
,
Yige Bao1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China
,
Qiang Dong1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China
,
Liangren Liu1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Qiang Wei1 Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu610041, People’s Republic of China
 show all
Pages 7639-7645 | Published online: 14 Aug 2019

References

  • Ding Q, Wei Q, Yin C, et al. Chinese Association of Urology Guidelines on Testicular Cancer. People's Medical Publishing House; 2014.
  • Chahoud J, Zhang M, Shah A, Lin S-H, Pisters LL, Tu S-M. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol. 2018. doi:10.1097/cco.0000000000000446
  • Albers P, Albrecht W, Algaba F, et al. EAU guidelines on testicular cancer. EAU Guidelines. 2018(1).
  • Timothy G, Daniel WL, Rahul A, et al. NCCN clinical practice guidelines in oncology on testicular cancer. NCCN Guidelines. 2018;1.
  • Groot HJ, Lubberts S, de Wit R, et al. Risk of solid cancer after treatment of testicular germ cell cancer. J Clin Oncol. 2018;36:2504–2515. doi:10.1200/JCO10.1200/JCO.201729989856
  • Chovanec M, Hanna N, Cary KC, Einhorn L, Albany C. Management of stage I testicular germ cell tumours. Nat Rev Urol. 2016;13:663–673. doi:10.1038/nrurol.2016.16427618772
  • Kamran SC, Seisen T, Markt SC, et al. Contemporary treatment patterns and outcomes for clinical stage IS testicular cancer. Eur Urol. 2017;73:262–270. doi:10.1016/j.eururo.2017.06.01328687143
  • Trevino KE, Esmaeili-Shandiz A, Saeed O, Xu H, Ulbright TM, Idrees MT. Pathological risk factors for higher clinical stage in testicular seminomas. Histopathology. 2018;73:741–747. doi:10.1111/his.1366729858564
  • Tyrrell HEJ, Church DN, Joseph J, et al. Changing practice evaluation-stage 1 seminoma: outcomes with adjuvant treatment versus surveillance: risk factors for recurrence and optimizing follow-up protocols-experience from a supraregional center. Clin Genitourin Cancer. 2018;16:240–244. doi:10.1016/j.clgc.2017.12.00129336917
  • Tandstad T, Ståhl O, Dahl O, et al. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol. 2016;27:1299–1304. doi:10.1093/annonc/mdw16427052649
  • Zengerling F, Kunath F, Jensen K, Ruf C, Schmidt S, Spek A. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review. Urol Oncol. 2018;36:448–458. doi:10.1016/j.urolonc.2017.06.04728712790
  • Dieckmann KP, Dralle-Filiz I, Matthies C, et al. Testicular seminoma clinical stage 1: treatment outcome on a routine care level. J Cancer Res Clin Oncol. 2016;142:1599–1607. doi:10.1007/s00432-016-2162-z27116691
  • Berghen C, Albersen M, Blanchard P, et al. Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay. BJU Int. 2019. doi:10.1111/bju.14686
  • Maroto P, Anguera G, Martin C. Long-term toxicity of the treatment for germ cell-cancer. A review. Crit Rev Oncol Hematol. 2018;121:62–67. doi:10.1016/j.critrevonc.2017.11.01529279100
  • Glaser SM, Vargo JA, Balasubramani GK, Beriwal S. Stage II testicular seminoma: patterns of care and survival by treatment strategy. Clin Oncol. 2016;28:513–521. doi:10.1016/j.clon.2016.02.008
  • Miki T, Kamoi K, Fujimoto H, et al. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association. Int J Urol. 2014;21:S1–S6. doi:10.1111/iju.1244124725194

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.